Barry S. Komm - Concepedia

Author

Barry S. Komm

Pfizer (United States)

Also Known As

B Komm, B S Komm, B. Komm, B. S. Komm, B.S Komm, B.S. Komm, BARRY KOMM, BARRY S. KOMM, Barry Komm, Barry S Komm

192

Publications

13.5K

Citations

H-Index

127

Concepts

All Affiliations

Pfizer (United States)Women's Health Research Institute University of Pennsylvania University of Illinois Urbana-Champaign University of Arizona

About

Barry S. Komm is an author at Pfizer (United States) specializing in medicine, endocrinology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	37	53	7.9K
2	Natural Sciences	10	10	2K
3	Public Health	9	9	435
4	Health Sciences	8	8	881
5	Engineering	2	2	585

Barry S. Komm

Publications

11.8K

Citations

H-Index

Page 1

	Year	Citations
Canonical WNT Signaling Promotes Osteogenesis by Directly Stimulating Runx2 Gene Expression Tripti Gaur, Christopher J. Lengner, Hayk Hovhannisyan, Journal of Biological Chemistry SclerostinDevelopmental BiologyBone Morphogenic ProteinNull MutationsCell Signaling	2005	1.1K
Profiling of Estrogen Up- and Down-Regulated Gene Expression in Human Breast Cancer Cells: Insights into Gene Networks and Pathways Underlying Estrogenic Control of Proliferation and Cell Phenotype Jonna Frasor, Jeanne M. Danes, Barry S. Komm, Endocrinology Breast OncologyGlobal Gene ExpressionEstrogen Up-Gene Regulatory NetworkGene Expression Profiling	2003	877
Estrogen Binding, Receptor mRNA, and Biologic Response in Osteoblast-Like Osteosarcoma Cells Barry S. Komm, Christopher Terpening, D. Benz, Science Human Osteosarcoma CellsDissociation ConstantGynecologyBiologic ResponseOsteoporosis	1988	822
Wnt/β-Catenin Signaling Is a Normal Physiological Response to Mechanical Loading in Bone John A. Robinson, Moitreyee Chatterjee‐Kishore, Paul J. Yaworsky, Journal of Biological Chemistry MechanobiologyEngineeringOrthopaedic SurgeryMedicinePhysiology	2006	495
The Wnt Antagonist Secreted Frizzled-Related Protein-1 Is a Negative Regulator of Trabecular Bone Formation in Adult Mice Peter V.N. Bodine, Weiguang Zhao, Yogendra P. Kharode, Molecular Endocrinology SclerostinOsteoporosisMurine Wnt AntagonistBone BiologyBone Morphogenic Protein	2004	443
Selective Estrogen Receptor Modulators Jonna Frasor, Fabio Stossi, Jeanne M. Danes, Cancer Research	2004	398
Impact of Estrogen Receptor β on Gene Networks Regulated by Estrogen Receptor α in Breast Cancer Cells Edmund C. Chang, Jonna Frasor, Barry S. Komm, Endocrinology	2006	323
RETRACTED: Estrogen receptor-interacting protein that modulates its nongenomic activity-crosstalk with Src/Erk phosphorylation cascade Chi‐Wai Wong, Christopher J. McNally, Elliot Nickbarg, Proceedings of the National Academy of Sciences	2002	322
Evaluation of an Estrogen Receptor-β Agonist in Animal Models of Human Disease Heather A. Harris, Leo Albert, Yelena Leathurby, Endocrinology Estrogen ActionPharmacotherapyFemale Reproductive FunctionOsteoporosisMolecular Pharmacology	2003	312
Bazedoxifene Acetate: A Selective Estrogen Receptor Modulator with Improved Selectivity Barry S. Komm, Yogendra P. Kharode, Peter V.N. Bodine, Endocrinology Hormonal ContraceptiveMedicineHormonal ReceptorPhysiologyBazedoxifene Acetate	2005	296

Page 1